Answers to the CME Quiz for "Premature Ovarian Failure" by Robert W. Rebar, MD (Obstet Gynecol 2009;113[6])

1. The term “primary ovarian insufficiency” is preferred to the term “premature ovarian failure” by some clinicians because:

C. Pregnancy can still occur

2. The most common autoimmune disorder associated with primary ovarian insufficiency is:

C. Thyroiditis

3. The usual threshold value of follicle-stimulating hormone for the diagnosis of primary ovarian insufficiency is:

C. 30 milli-International Units per milliliter

4. In patients with primary ovarian insufficiency, hormone therapy may be ineffective in preventing:

C. Pregnancy

5. Of the following, the most appropriate contraceptive method to suggest for women with ovarian insufficiency is:

C. Barrier methods

6. In patients with primary ovarian insufficiency, the most effective way of achieving pregnancy is:

C. Donor oocytes with in vitro fertilization

7. The strongest argument against the use of progestin in the diagnosis of amenorrhea is:

C. Low positive predictive value

8. Women diagnosed with Turner syndrome should be discouraged from carrying any pregnancy because of the risk of:

C. Maternal aortic rupture

ACCME Accreditation: The American College of Obstetricians and Gynecologists (ACOG) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. (Continuing medical education credit for "Premature Ovarian Failure" will be available through June 2012.)

AMA PRA Category 1 Credit^TM and ACOG Cognate Credit: The American College of Obstetricians and Gynecologists (ACOG) designates this educational activity for a maximum of 2 AMA PRA Category 1 Credits^TM or up to a maximum of 2 Category 1 ACOG cognate credits. Physicians should only claim credit commensurate with the extent of their participation in the activity.

Disclosure Statement: Current guidelines state that continuing medical education (CME) providers must ensure that CME activities are free from the control of any commercial interest. All authors, reviewers, and contributors have disclosed to ACOG all relevant financial relationships with any commercial interests. The authors, reviewers, and contributors declare that neither they nor any business associate nor any member of their immediate families has financial interest or other relationships with any manufacturer of products or any providers of services discussed in this program. Any conflicts have been resolved through group and outside review of all content.

Return to the Obstetrics & Gynecology web site.